<unk> , sold under the brand name Jivi is a recombinant DNA-derived, Factor VIII concentrate medication used to treat hemophilia A. The most common side effects include headache, cough, nausea and fever.<unk>  (antihemophilic factor- recombinant<unk> ated-aucl) was approved for medical use in the United States in August 2018, and in the European Union in November 2018. __TOC__
Damoctocog alfa pegol
Efgartigimod alfa
Susoctocog alfa
Vonicog alfa
Efmoroctocog alfa
Ciltacabtagene autoleucel
Levomilnacipran
Brexucabtagene autoleucel